AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20120423 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone gel 5% combined with benzoyl peroxide gel 4%
Number of subjects: 301
Study 20120423 — intervention group
Group type: COMPARATOR
Intervention: Dapsone gel 5% combined with moisturizer
Number of subjects: 301
Study 17849435 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise programme (training once a day)
Number of subjects: 57
Study 17849435 — intervention group
Group type: COMPARATOR
Intervention: Control group (without exercise)
Number of subjects: 57
Study 15857227 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring System (CGMS) for patients with type 1 diabetes
Number of subjects: 20
Study 15857227 — intervention group
Group type: COMPARATOR
Intervention: Continuous Glucose Monitoring System (CGMS) for healthy controls
Number of subjects: 20
Study 15857227 — intervention group
Group type: EXPERIMENTAL
Intervention: CONGA (Continuous overall net glycemic action)
Number of subjects: 20
Study 12385861 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta‐oestradiol/norethisterone acetate
Number of subjects: 80
Study 12385861 — intervention group
Group type: EXPERIMENTAL
Intervention: tibolone
Number of subjects: 80
Study 10592724 — intervention group
Group type: EXPERIMENTAL
Intervention: Very extensive metabolizers of sparteine (patients with allergic diseases)
Number of subjects: 200
Study 10592724 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 200
Study 10592724 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with very extensive oxidation phenotype
Number of subjects: 200
Study 8909483 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-meningococcal protein conjugate (M) at 2 months followed by PRP-tetanus toxoid conjugate (T) at 4 and 6 months
Number of subjects: 321
Study 8909483 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose mixed regimen (M at 2 months and T at 4 months)
Number of subjects: 321
Study 8909483 — intervention group
Group type: COMPARATOR
Intervention: Three-dose TTT regimen
Number of subjects: 321
Study 8909483 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dose mixed regimen (MT-)
Number of subjects: 321
Study 1858696 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 45
Study 1858696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 6405772 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 60 mg by mouth
Number of subjects: 6
Study 6405772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31813423 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training (TOT)
Number of subjects: 46
Study 29806413 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoelectric guided navigation unilateral puncture of the percutaneous kyphoplasty (PKP)
Number of subjects: 85
Study 29806413 — intervention group
Group type: COMPARATOR
Intervention: C arm fluoroscopy unilateral puncture of the percutaneous kyphoplasty (PKP)
Number of subjects: 85
Study 26845273 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic polypharmacy (APP)
Number of subjects: 35
Study 26845273 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic monotherapy (APM)
Number of subjects: 35
Study 24872442 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (EP) consisting of three, 55‐ to 60‐min sessions per week throughout pregnancy
Number of subjects: 184
Study 24872442 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 184
Study 22820469 — intervention group
Group type: EXPERIMENTAL
Intervention: Unworn silicone hydrogel lenses
Number of subjects: 10
Study 22820469 — intervention group
Group type: EXPERIMENTAL
Intervention: Worn silicone hydrogel lenses
Number of subjects: 10
Study 22820469 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lenses (general)
Number of subjects: 10
Study 22820469 — intervention group
Group type: EXPERIMENTAL
Intervention: P. aeruginosa
Number of subjects: 10
Study 20150814 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention at a community hospital without on-site surgical backup
Number of subjects: 609
Study 20150814 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention at a regional hospital with on-site surgical backup
Number of subjects: 609
Study 20150814 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hospitals (with and without surgical backup)
Number of subjects: 609
Study 19033147 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-assisted tobacco interventions (WATI)
Number of subjects: 0
Study 16038681 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD subjects
Number of subjects: 14
Study 16038681 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 14
Study 12490031 — intervention group
Group type: EXPERIMENTAL
Intervention: TAMMEF (musically modulated electromagnetic field)
Number of subjects: 150
Study 12490031 — intervention group
Group type: COMPARATOR
Intervention: ELF (100 Hz electromagnetic field)
Number of subjects: 150
Study 12490031 — intervention group
Group type: COMPARATOR
Intervention: Simulated treatment
Number of subjects: 150
Study 10634161 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium citrate (250 mL) and bisacodyl (10 mg, orally)
Number of subjects: 70
Study 10634161 — intervention group
Group type: COMPARATOR
Intervention: Castor oil (60 mL, orally)
Number of subjects: 70
Study 7572119 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy (RT)
Number of subjects: 1358
Study 7572119 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative radiotherapy (RT)
Number of subjects: 1358
Study 1959859 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral amino acid administration (2 l/day of a solution of dextrose (65 gm/L) and amino acids (25.8 gm/L) for 1 month)
Number of subjects: 54
Study 1959859 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral amino acid administration
Number of subjects: 54
Study 1959859 — intervention group
Group type: COMPARATOR
Intervention: Control (dextrose solution only)
Number of subjects: 54
Study 6394008 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 682
Study 6394008 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 682
Study 31610948 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-open antegrade intramedullary nailing (AIN)
Number of subjects: 75
Study 31610948 — intervention group
Group type: COMPARATOR
Intervention: Low-profile locking plate
Number of subjects: 75
Study 27258736 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoralen plus ultraviolet A (PUVA) for 90 days
Number of subjects: 50
Study 27258736 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B (NB-UVB) for 90 days
Number of subjects: 50
Study 27572830 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-063 (1000 mg)
Number of subjects: 84
Study 27572830 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-063 (100 mg) under fed conditions
Number of subjects: 84
Study 27572830 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-063 (various doses)
Number of subjects: 84
Study 27572830 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS Vital Signs cognitive assessment
Number of subjects: 84
Study 27572830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 24399265 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat-based complementary feeding
Number of subjects: 1236
Study 24399265 — intervention group
Group type: COMPARATOR
Intervention: Fortified cereal complementary feeding
Number of subjects: 1236
Study 24399265 — intervention group
Group type: EXPERIMENTAL
Intervention: Study messages (general intervention)
Number of subjects: 1236
Study 21909815 — intervention group
Group type: EXPERIMENTAL
Intervention: batroxobin (group B)
Number of subjects: 80
Study 21909815 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid (TXA) (group C)
Number of subjects: 80
Study 21909815 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of batroxobin and TXA (group D)
Number of subjects: 80
Study 21909815 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (group A)
Number of subjects: 80
Study 19132338 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin (0.0005 U/kg/min)
Number of subjects: 24
Study 19132338 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (0.9%)
Number of subjects: 24
Study 17663820 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin enteric-coated soft capsules (50 IU)
Number of subjects: 20
Study 17663820 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin (15 IU)
Number of subjects: 20
Study 17602979 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 3029
Study 15641629 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol HFA 134A MDI (FSC)
Number of subjects: 360
Study 15641629 — intervention group
Group type: COMPARATOR
Intervention: Placebo HFA 134a (PLA)
Number of subjects: 360
Study 15641629 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 44 microg CFC (FP)
Number of subjects: 360
Study 15641629 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 21 microg CFC (S)
Number of subjects: 360
Study 10678408 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 23
Study 10678408 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study 10678408 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 23
Study 10678408 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 23
Study 9352280 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler imaging (CDI) in patients with mild to moderate vasculitis
Number of subjects: 50
Study 9352280 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler imaging (CDI) in patients with severe vasculitis
Number of subjects: 50
Study 9352280 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 50
Study 8211801 — intervention group
Group type: EXPERIMENTAL
Intervention: Theopek taken twice daily
Number of subjects: 59
Study 8211801 — intervention group
Group type: EXPERIMENTAL
Intervention: Euphylong taken in a single daily dose
Number of subjects: 59
Study 3082230 — intervention group
Group type: EXPERIMENTAL
Intervention: metrifonate (10 mg/kg body weight, twice)
Number of subjects: 156
Study 3082230 — intervention group
Group type: EXPERIMENTAL
Intervention: oxamniquine (60 mg/kg)
Number of subjects: 156
Study 3082230 — intervention group
Group type: EXPERIMENTAL
Intervention: praziquantel (40 mg/kg)
Number of subjects: 156
Study 3082230 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 156
Study 31835620 — intervention group
Group type: COMPARATOR
Intervention: Zanthoxylum armatum (ZA) extract (single dose on Day 1)
Number of subjects: 82
Study 31835620 — intervention group
Group type: COMPARATOR
Intervention: Zanthoxylum armatum (ZA) extract (56 days supplementation)
Number of subjects: 82
Study 31835620 — intervention group
Group type: COMPARATOR
Intervention: Zanthoxylum armatum (ZA) extract (Day 1 and Day 56)
Number of subjects: 82
Study 31835620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 28424902 — intervention group
Group type: EXPERIMENTAL
Intervention: AYA
Number of subjects: 205
Study 28424902 — intervention group
Group type: COMPARATOR
Intervention: non-AYA
Number of subjects: 205
Study 28424902 — intervention group
Group type: EXPERIMENTAL
Intervention: AYA and non-AYA
Number of subjects: 205
Study 25944520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Number of subjects: 849
Study 24473958 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion group (CIG)
Number of subjects: 140
Study 24473958 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent infusion group (IIG)
Number of subjects: 140
Study 24473958 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 140
Study 21879896 — intervention group
Group type: EXPERIMENTAL
Intervention: Early analysis of cardiac rhythm (30 to 60 seconds of CPR before analysis)
Number of subjects: 9933
Study 21879896 — intervention group
Group type: COMPARATOR
Intervention: Later analysis of cardiac rhythm (180 seconds of CPR before analysis)
Number of subjects: 9933
Study 19700284 — intervention group
Group type: EXPERIMENTAL
Intervention: EasyTube (EzT)
Number of subjects: 200
Study 19700284 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 200
Study 16525751 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt (375 g/d)
Number of subjects: 32
Study 16525751 — intervention group
Group type: COMPARATOR
Intervention: Semi-skimmed milk (400 ml/d)
Number of subjects: 32
Study 14722539 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation
Number of subjects: 40
Study 14722539 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic surveillance
Number of subjects: 40
Study 11216725 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular defect
Number of subjects: 12
Study 11216725 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectangular defect
Number of subjects: 12
Study 11216725 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular defect
Number of subjects: 12
Study 11216725 — intervention group
Group type: COMPARATOR
Intervention: Comparison between defect shapes
Number of subjects: 12
Study 11216725 — intervention group
Group type: COMPARATOR
Intervention: Mode of failure
Number of subjects: 12
Study 9684746 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubiquinone supplementation (180 mg daily)
Number of subjects: 19
Study 9684746 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin therapy
Number of subjects: 19
Study 7798851 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal regimen (0.1 ml at two sites on days 0, 3, 7 and 0.1 ml at one site on days 30 and 90)
Number of subjects: 100
Study 7798851 — intervention group
Group type: COMPARATOR
Intervention: Standard intramuscular regimen
Number of subjects: 100
Study 3391735 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric bypass
Number of subjects: 51
Study 3391735 — intervention group
Group type: COMPARATOR
Intervention: Gastroplasty
Number of subjects: 51
Study 31421838 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanochemical ablation (MOCA)
Number of subjects: 66
Study 31421838 — intervention group
Group type: COMPARATOR
Intervention: Thermal ablation (radiofrequency ablation and endovenous laser therapy)
Number of subjects: 66
Study 31421838 — intervention group
Group type: COMPARATOR
Intervention: Thermal ablation
Number of subjects: 66
Study 28117241 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient specific rehearsal (PsR) prior to EVAR
Number of subjects: 100
Study 28117241 — intervention group
Group type: COMPARATOR
Intervention: Post-operative PsR
Number of subjects: 100
Study 26342026 — intervention group
Group type: EXPERIMENTAL
Intervention: High methylation index of AGTR1, FOXI2, and PENK promoters
Number of subjects: 68
Study 26342026 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of LINE1 methylation
Number of subjects: 68
Study 23845305 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel 25 mg/kg
Number of subjects: 53
Study 23845305 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel 50 mg/kg
Number of subjects: 53
Study 23845305 — intervention group
Group type: COMPARATOR
Intervention: Control group (no praziquantel)
Number of subjects: 53
Study 21406147 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection using the VibraJect
Number of subjects: 90
Study 21406147 — intervention group
Group type: COMPARATOR
Intervention: Injection as usual (control)
Number of subjects: 90
Study 19921358 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal injection of 0.5% isobaric bupivacaine, 2.8 ml plus morphine, 0.05 mg (Group B)
Number of subjects: 20
Study 19921358 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal injection of 0.5% isobaric bupivacaine, 2.8 ml (Group A)
Number of subjects: 20
Study 16513860 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 335
Study 16513860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study 15041008 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anaesthesia with Xylocain solution
Number of subjects: 20
Study 15041008 — intervention group
Group type: COMPARATOR
Intervention: Physiological Sodium solution (Control)
Number of subjects: 20
Study 11230036 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline predictors of frequent contact
Number of subjects: 0
Study 11230036 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued frequent contact after 2 years
Number of subjects: 0
Study 9066031 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid combination of DTP-PRP-T vaccine
Number of subjects: 262
Study 9066031 — intervention group
Group type: COMPARATOR
Intervention: Lyophilized PRP-T reconstituted with DTP
Number of subjects: 262
Study 8446136 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up colonoscopy at one and three years
Number of subjects: 1418
Study 8446136 — intervention group
Group type: COMPARATOR
Intervention: Follow-up colonoscopy at three years only
Number of subjects: 1418
Study 3530137 — intervention group
Group type: COMPARATOR
Intervention: MF (Mitomycin and 5-Fluorouracil)
Number of subjects: 64
Study 3530137 — intervention group
Group type: EXPERIMENTAL
Intervention: MF.BH-AC (Mitomycin, 5-Fluorouracil, and BH-AC)
Number of subjects: 64
Study 29678360 — intervention group
Group type: EXPERIMENTAL
Intervention: HerSwab™ self-sampling
Number of subjects: 1217
Study 29678360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobas® swab self-sampling
Number of subjects: 1217
Study 29678360 — intervention group
Group type: COMPARATOR
Intervention: Physician-collected sample
Number of subjects: 1217
Study 29678360 — intervention group
Group type: COMPARATOR
Intervention: Cytology on physician-collected specimen
Number of subjects: 1217
Study 26892135 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosabutate 600 mg once daily
Number of subjects: 87
Study 26892135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 25799306 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative borderline personality disorder-oriented adolescent family therapy (I-BAFT)
Number of subjects: 40
Study 25799306 — intervention group
Group type: COMPARATOR
Intervention: Individual drug counseling
Number of subjects: 40
Study 25799306 — intervention group
Group type: EXPERIMENTAL
Intervention: I-BAFT
Number of subjects: 40
Study 24120551 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased testosterone levels in men
Number of subjects: 201
Study 24120551 — intervention group
Group type: EXPERIMENTAL
Intervention: Fearless dominance (FD) in men
Number of subjects: 201
Study 24120551 — intervention group
Group type: EXPERIMENTAL
Intervention: Fearless dominance (FD) in women
Number of subjects: 201
Study 24120551 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-centered impulsivity (SCI) in women
Number of subjects: 201
Study 24120551 — intervention group
Group type: COMPARATOR
Intervention: Baseline testosterone concentrations
Number of subjects: 201
Study 24120551 — intervention group
Group type: COMPARATOR
Intervention: Cortisol concentrations
Number of subjects: 201
Study 22135493 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV (using the Synchrony BiPAP device) for 6 months
Number of subjects: 15
Study 22135493 — intervention group
Group type: COMPARATOR
Intervention: Routine pharmacological treatment (Control)
Number of subjects: 15
Study 19024257 — intervention group
Group type: EXPERIMENTAL
Intervention: Violight toothbrush holder
Number of subjects: 25
Study 19024257 — intervention group
Group type: COMPARATOR
Intervention: Control group (rinsed toothbrushes in cold tap water)
Number of subjects: 25
Study 16801034 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic navigation system
Number of subjects: 71
Study 16801034 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual methods
Number of subjects: 71
Study 12671949 — intervention group
Group type: EXPERIMENTAL
Intervention: Piribedil 150 mg/day
Number of subjects: 115
Study 12671949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 10881249 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]Flumazenil PET
Number of subjects: 16
Study 9256323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postoperative ADM instillation (Group C)
Number of subjects: 200
Study 9256323 — intervention group
Group type: COMPARATOR
Intervention: Postoperative ADM instillation alone (Group A)
Number of subjects: 200
Study 9256323 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative ADM plus 5-FU (Group B)
Number of subjects: 200
Study 9256323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postoperative ADM plus 5-FU (Group D)
Number of subjects: 200
Study 8497831 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (Phyllocontin; 350 mg twice daily)
Number of subjects: 9
Study 8497831 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (Volmax; 8 mg twice daily)
Number of subjects: 9
Study 8497831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 3543093 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin therapy (50 mg every 12 hours for 2 months)
Number of subjects: 21
Study 3543093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 30252699 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible Reinforced Laryngeal Mask Airway (FLMA)
Number of subjects: 132
Study 30252699 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 132
Study 29802820 — intervention group
Group type: EXPERIMENTAL
Intervention: 200g red raspberries (201 mg total (poly)phenols)
Number of subjects: 10
Study 29802820 — intervention group
Group type: EXPERIMENTAL
Intervention: 400g red raspberries (403 mg total (poly)phenols)
Number of subjects: 10
Study 29802820 — intervention group
Group type: COMPARATOR
Intervention: matched control drink
Number of subjects: 10
Study 28032465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide before breakfast
Number of subjects: 69
Study 28032465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide before main meal
Number of subjects: 69